Immune Related Adverse Events (irAEs)

The hosts dive into the fascinating world of immune checkpoint inhibitors and their impact on cancer treatment. They discuss the mechanisms behind immunotherapy and the rise of immune-related adverse events (irAEs). Key management strategies for common side effects are explored, including dermatologic and gastrointestinal reactions. The conversation highlights the importance of patient education and the need for coordinated care with specialists to handle challenging toxicities, especially for those with autoimmune histories.